In addition, the treatment of HSC-engrafted NSG-SGM3 mice bearing melanoma tumors with anti-PD1 combined with Flt3-L and a toll like receptor (TLR)-3 agonist resulted in a synergistic effect leading to limit the tumor growth. The gene discussed is PDCD1; the disease is melanoma.